119 related articles for article (PubMed ID: 38892218)
1. Circulating Trimethylamine-N-Oxide Is Elevated in Liver Transplant Recipients.
Trillos-Almanza MC; Chvatal-Medina M; Connelly MA; Moshage H; TransplantLines Investigators ; Bakker SJL; de Meijer VE; Blokzijl H; Dullaart RPF
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892218
[TBL] [Abstract][Full Text] [Related]
2. Association of Circulating Trimethylamine
Flores-Guerrero JL; Osté MCJ; Baraldi PB; Connelly MA; Garcia E; Navis G; Bakker SJL; Dullaart RPF
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33477634
[TBL] [Abstract][Full Text] [Related]
3. High plasma levels of betaine, a trimethylamine N-Oxide-related metabolite, are associated with the severity of cirrhosis.
van den Berg EH; Flores-Guerrero JL; Garcia E; Connelly MA; de Meijer VE; ; Bakker SJL; Blokzijl H; Dullaart RPF
Liver Int; 2023 Feb; 43(2):424-433. PubMed ID: 35585781
[TBL] [Abstract][Full Text] [Related]
4. Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease.
Flores-Guerrero JL; Post A; van Dijk PR; Connelly MA; Garcia E; Navis G; Bakker SJL; Dullaart RPF
Liver Int; 2021 Oct; 41(10):2371-2382. PubMed ID: 33993608
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
[TBL] [Abstract][Full Text] [Related]
7. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
8. Plasma trimethylamine n-oxide is associated with renal function in patients with heart failure with preserved ejection fraction.
Guo F; Qiu X; Tan Z; Li Z; Ouyang D
BMC Cardiovasc Disord; 2020 Aug; 20(1):394. PubMed ID: 32859154
[TBL] [Abstract][Full Text] [Related]
9. Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes.
Croyal M; Saulnier PJ; Aguesse A; Gand E; Ragot S; Roussel R; Halimi JM; Ducrocq G; Cariou B; Montaigne D; Wargny M; Krempf M; Hadjadj S
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32301490
[TBL] [Abstract][Full Text] [Related]
10. Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease.
Senthong V; Wang Z; Fan Y; Wu Y; Hazen SL; Tang WH
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792653
[TBL] [Abstract][Full Text] [Related]
11. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
12. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
[TBL] [Abstract][Full Text] [Related]
13. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
[TBL] [Abstract][Full Text] [Related]
15. Increasing trimethylamine N-oxide levels as a predictor of early neurological deterioration in patients with acute ischemic stroke.
Hou L; Zhang Y; Zheng D; Shi H; Zou C; Zhang H; Lu Z; Du H
Neurol Res; 2020 Feb; 42(2):153-158. PubMed ID: 31928326
[No Abstract] [Full Text] [Related]
16. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.
Senthong V; Wang Z; Li XS; Fan Y; Wu Y; Tang WH; Hazen SL
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27287696
[TBL] [Abstract][Full Text] [Related]
17. Relationship between Plasma Trimethylamine N-Oxide Levels and Renal Dysfunction in Patients with Hypertension.
Zhou J; Wang D; Li B; Li X; Lai X; Lei S; Li N; Zhang X
Kidney Blood Press Res; 2021; 46(4):421-432. PubMed ID: 34233325
[TBL] [Abstract][Full Text] [Related]
18. Trimethylamine-N-oxide (TMAO) determined by LC-MS/MS: distribution and correlates in the population-based PopGen cohort.
Gessner A; di Giuseppe R; Koch M; Fromm MF; Lieb W; Maas R
Clin Chem Lab Med; 2020 Apr; 58(5):733-740. PubMed ID: 32084001
[TBL] [Abstract][Full Text] [Related]
19. A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO).
Barrea L; Muscogiuri G; Annunziata G; Laudisio D; de Alteriis G; Tenore GC; Colao A; Savastano S
Nutrients; 2019 Jun; 11(6):. PubMed ID: 31185686
[No Abstract] [Full Text] [Related]
20. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
